Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2007) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacology and Therapeutics | journal | 3.796 Q1 | 233 | 111 | 274 | 19051 | 2587 | 270 | 8.84 | 171.63 |  |
| 2 | Current Neuropharmacology | journal | 0.489 Q2 | 103 | 27 | 83 | 3824 | 86 | 79 | 0.94 | 141.63 |  |
| 3 | Drug Resistance Updates | journal | 2.935 Q1 | 132 | 17 | 78 | 2301 | 604 | 75 | 7.15 | 135.35 | |
| 4 | Current Signal Transduction Therapy | journal | 22 | 25 | 0 | 3246 | 0 | 0 | 0.00 | 129.84 | | |
| 5 | Recent Patents on CNS Drug Discovery | journal | 0.398 Q2 | 36 | 22 | 25 | 2775 | 29 | 25 | 1.16 | 126.14 | |
| 6 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.499 Q2 | 52 | 22 | 27 | 2750 | 35 | 27 | 1.30 | 125.00 | |
| 7 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 23 | 28 | 2501 | 21 | 28 | 0.75 | 108.74 | | |
| 8 | Expert Opinion on Emerging Drugs | journal | 0.950 Q1 | 54 | 45 | 124 | 4719 | 377 | 124 | 3.05 | 104.87 |  |
| 9 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 22 | 30 | 2265 | 26 | 30 | 0.87 | 102.95 | | |
| 10 | Advances in Antiviral Drug Design | book series | 12 | 7 | 0 | 624 | 0 | 0 | 0.00 | 89.14 | | |
| 11 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.160 Q3 | 30 | 27 | 27 | 2300 | 11 | 27 | 0.41 | 85.19 |  |
| 12 | CNS Drugs | journal | 1.470 Q1 | 129 | 86 | 275 | 6732 | 1306 | 245 | 4.70 | 78.28 | |
| 13 | Drugs and Aging | journal | 0.915 Q1 | 109 | 78 | 249 | 6090 | 795 | 234 | 3.01 | 78.08 | |
| 14 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 28 | 0 | 2149 | 0 | 0 | 0.00 | 76.75 | | |
| 15 | AIDS Reviews | journal | 1.564 Q1 | 62 | 26 | 92 | 1990 | 283 | 73 | 3.11 | 76.54 |  |
| 16 | Expert Review of Neurotherapeutics | journal | 0.542 Q2 | 98 | 183 | 375 | 13849 | 700 | 352 | 2.01 | 75.68 | |
| 17 | Therapeutic Advances in Cardiovascular Disease | journal | 41 | 12 | 0 | 898 | 0 | 0 | 0.00 | 74.83 | | |
| 18 | Drugs | journal | 1.205 Q1 | 188 | 213 | 655 | 15577 | 2827 | 523 | 3.73 | 73.13 | |
| 19 | Expert Opinion on Pharmacotherapy | journal | 0.577 Q2 | 93 | 274 | 698 | 20007 | 1543 | 685 | 2.23 | 73.02 | |
| 20 | Current Drug Therapy | journal | 20 | 30 | 0 | 2159 | 0 | 0 | 0.00 | 71.97 | | |
| 21 | Drug Metabolism Reviews | journal | 1.488 Q1 | 108 | 43 | 114 | 3050 | 560 | 112 | 4.28 | 70.93 | |
| 22 | Expert Opinion on Investigational Drugs | journal | 1.190 Q1 | 117 | 170 | 411 | 12057 | 1514 | 390 | 3.87 | 70.92 | |
| 23 | PPAR Research | journal | 0.450 Q2 | 59 | 40 | 12 | 2800 | 14 | 10 | 1.17 | 70.00 | |
| 24 | Biologics: Targets and Therapy | journal | 47 | 48 | 0 | 3348 | 0 | 0 | 0.00 | 69.75 |  | |
| 25 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 51 | 101 | 3531 | 1 | 52 | 0.02 | 69.24 | |
| 26 | BioDrugs | journal | 0.787 Q2 | 79 | 46 | 112 | 3178 | 323 | 110 | 2.87 | 69.09 | |
| 27 | Neurotherapeutics | journal | 2.567 Q1 | 136 | 80 | 162 | 5502 | 1103 | 146 | 6.15 | 68.78 | |
| 28 | Orphanet Journal of Rare Diseases | journal | 0.570 Q2 | 136 | 50 | 51 | 3352 | 100 | 50 | 1.96 | 67.04 | |
| 29 | Drugs of Today | journal | 0.541 Q2 | 57 | 72 | 247 | 4811 | 521 | 244 | 2.18 | 66.82 | |
| 30 | Expert Review of Anticancer Therapy | journal | 0.788 Q2 | 85 | 175 | 415 | 11668 | 812 | 370 | 2.18 | 66.67 | |
| 31 | Clinical Pharmacokinetics | journal | 1.429 Q1 | 184 | 68 | 241 | 4519 | 1307 | 232 | 4.92 | 66.46 | |
| 32 | Therapeutic Advances in Respiratory Disease | journal | 50 | 10 | 0 | 656 | 0 | 0 | 0.00 | 65.60 | | |
| 33 | Cancer and Chemotherapy Reviews | journal | 4 | 20 | 0 | 1307 | 0 | 0 | 0.00 | 65.35 | | |
| 34 | Current Topics in Pharmacology | journal | 0.108 Q4 | 8 | 18 | 18 | 1118 | 2 | 18 | 0.11 | 62.11 |  |
| 35 | Expert Opinion on Drug Safety | journal | 0.813 Q2 | 90 | 74 | 240 | 4552 | 731 | 205 | 3.00 | 61.51 | |
| 36 | Targeted Oncology | journal | 0.239 Q3 | 59 | 29 | 34 | 1782 | 14 | 30 | 0.41 | 61.45 |  |
| 37 | Current Drug Safety | journal | 0.218 Q3 | 41 | 30 | 33 | 1789 | 23 | 33 | 0.70 | 59.63 | |
| 38 | American Journal of Cardiovascular Drugs | journal | 0.786 Q2 | 60 | 51 | 132 | 3025 | 388 | 126 | 3.02 | 59.31 | |
| 39 | Primary Care - Clinics in Office Practice | journal | 0.234 Q3 | 59 | 49 | 176 | 2840 | 214 | 164 | 1.20 | 57.96 | |
| 40 | Vascular Health and Risk Management | journal | 0.224 Q3 | 82 | 114 | 100 | 6548 | 58 | 94 | 0.58 | 57.44 | |
| 41 | Experimental and Clinical Psychopharmacology | journal | 0.964 Q1 | 101 | 60 | 124 | 3417 | 301 | 123 | 2.30 | 56.95 | |
| 42 | Annals of Cancer Research and Therapy | journal | 0.140 Q3 | 7 | 9 | 25 | 505 | 11 | 24 | 0.29 | 56.11 | |
| 43 | Journal of Pharmacy Practice | journal | 0.147 Q3 | 38 | 49 | 148 | 2722 | 36 | 132 | 0.20 | 55.55 | |
| 44 | Therapeutics and Clinical Risk Management | journal | 0.148 Q3 | 70 | 126 | 47 | 6910 | 11 | 43 | 0.23 | 54.84 | |
| 45 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.336 Q2 | 56 | 75 | 215 | 4091 | 249 | 214 | 1.05 | 54.55 | |
| 46 | Journal of Psychiatry and Neuroscience | journal | 1.791 Q1 | 114 | 46 | 140 | 2475 | 593 | 117 | 3.30 | 53.80 |  |
| 47 | Drugs of the Future | journal | 0.278 Q3 | 46 | 120 | 1347 | 6411 | 259 | 356 | 0.23 | 53.43 | |
| 48 | Cochrane Database of Systematic Reviews | journal | 1.490 Q1 | 327 | 1066 | 1635 | 55795 | 7964 | 1634 | 4.70 | 52.34 | |
| 49 | Paediatric Drugs | journal | 0.736 Q2 | 70 | 59 | 98 | 2905 | 263 | 90 | 2.43 | 49.24 | |
| 50 | Current Treatment Options in Oncology | journal | 0.838 Q1 | 66 | 39 | 144 | 1904 | 338 | 144 | 2.50 | 48.82 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data